Doris Lanz

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Markus Borner, Dieter Koeberle, Roger von Moos et al. · Annals of Oncology · 2008 · 127 citations · Full text

Swiss Group, Oncology, Gastrointestinal Oncology +10

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

Markus Borner, J. Bernhard, Damien Dietrich et al. · Annals of Oncology · 2005 · 102 citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +8

Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO)

Khalid S. Khan, Philip Moore, Matthew Wilson et al. · PLoS Medicine · 2017 · 69 citations · Full text

A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial

Khalid S. Khan, Philip Moore, Matthew Wilson et al. · Health Technology Assessment · 2018 · 59 citations · Full text

Pilot study of a cluster randomised trial of a guided e-learning health promotion intervention for managers based on management standards for the improvement of employee well-being and reduction of sickness absence: GEM Study

Stephen Stansfeld, Sally Kerry, Tarani Chandola et al. · BMJ Open · 2015 · 55 citations · Full text